Compare BWMN & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BWMN | IRWD |
|---|---|---|
| Founded | 1995 | 1998 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 620.2M | 741.8M |
| IPO Year | N/A | N/A |
| Metric | BWMN | IRWD |
|---|---|---|
| Price | $33.09 | $4.79 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 4 |
| Target Price | ★ $40.90 | $3.68 |
| AVG Volume (30 Days) | 117.1K | ★ 2.6M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $17.21 | N/A |
| Revenue Next Year | $9.62 | $37.22 |
| P/E Ratio | $35.20 | ★ $26.99 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $17.90 | $0.53 |
| 52 Week High | $45.83 | $5.78 |
| Indicator | BWMN | IRWD |
|---|---|---|
| Relative Strength Index (RSI) | 40.88 | 55.44 |
| Support Level | $33.16 | $4.22 |
| Resistance Level | $36.67 | $4.91 |
| Average True Range (ATR) | 1.59 | 0.33 |
| MACD | -0.15 | -0.07 |
| Stochastic Oscillator | 41.92 | 58.85 |
Bowman Consulting Group Ltd is a professional services firm delivering engineering solutions to customers who own, develop, and maintain the built environment. It provides planning, engineering, construction management, commissioning, environmental consulting, geospatial, survey, land procurement, and other technical services to customers operating in a diverse set of end markets. Its services include Civil & Site Engineering, Transportation Engineering, MEP Engineering, Commissioning & Energy Efficiency, Energy Services, Water/Wastewater, Fire Protection, Construction Management, Survey/Geospatial, Environmental Consulting, Structural Engineering, Land Procurement & Right-of-Way, Landscape and Architecture/Planning.
Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.